Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome

Time for a general approval of growth hormone treatment in adults with Prader–Willi syndrome

Abstract Prader-Willi syndrome (PWS) is a complex, multi-system, neurodevelopmental disorder characterised by neonatal muscular hypotonia, short stature, high risk of obesity, hypogonadism, intellectual disabilities, distinct behavioural/psychiatric problems and abnormal body composition with increa...

Full description

Bibliographic Details
Main Authors: Charlotte Höybye, Anthony J. Holland, Daniel J. Driscoll, The Clinical and Scientific Advisory Board of The International Prader-Willi Syndrome Organisation
Format: Article
Language:English
Published: BMC 2021-02-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Prader-willi syndrome
Growth hormone
Growth hormone treatment
Adults
Online Access:https://doi.org/10.1186/s13023-020-01651-x

Internet

https://doi.org/10.1186/s13023-020-01651-x

Similar Items